Cutibacterium acnes subsp. acnes (LMG 16711, DSM 1897, ATCC 6919)

Name: Cutibacterium acnes subsp. acnes (LMG 16711, DSM 1897, ATCC 6919)
Creator: BacDive
License: http://creativecommons.org/licenses/by/4.0/

BacDive ID 12636

Type strain

Culture col. no. LMG 16711 DSM 1897 ATCC 6919 CCUG 1794 JCM 6425 12 more

NCBI tax ID(s) 1747 1734925

Special Collections DSMZ CCUG JCM KCTC CIP Literature strains

History <- ATCC; ATCC 6919 <- NCTC; NCTC 737 <- A. Hayden; (Corynebacterium acnes) T. Mitsuoka <-- ATCC 6919 <-- NCTC 737 ("Corynebacterium acnes") <-- A. Hayden. CIP <- 1953, NCTC <- F. Hayden, London, UK

Links

Cutibacterium acnes subsp. acnes LMG 16711 is an anaerobe, mesophilic, Gram-positive prokaryote that was isolated from acne lesion in human facial skin.

Gram-positive rod-shaped anaerobe mesophilic genome sequence 16S sequence

Name and taxonomic classification

SI-ID 389260

LMG 3591,ATCC 6919,CCRC 10723,CCUG 1794,DSM 1897,JCM 6425,LMG 16711,NCTC 737,NBRC107605,VKM Ac-1450,CIP 53.117,KCTC 3314,KCTC 5008,AS 1.5003,NRRL B-4224,BCRC 10723,CCT 2592,CECT 5684,CGMCC 1.5003

@ref 20215

Last LPSN update 2026-02-09 11:20:53

Domain Bacteria

Phylum Actinomycetota

Class Actinomycetes

Order Propionibacteriales

Family Propionibacteriaceae

Genus Cutibacterium

Species Cutibacterium acnes subsp. acnes

Full scientific name Cutibacterium acnes subsp. acnes (Gilchrist 1900) Nouioui et al. 2018

Synonyms (2)

Propionibacterium acnes subsp. acnes
Propionibacterium acnes subsp. acnes

BacDive ID	Other strains from **Cutibacterium acnes subsp. acnes** (15)	Type strain
162333	C. acnes subsp. acnes JCM 18907
162334	C. acnes subsp. acnes JCM 18908
162336	C. acnes subsp. acnes JCM 18910
162338	C. acnes subsp. acnes JCM 18912
162342	C. acnes subsp. acnes JCM 18916
162343	C. acnes subsp. acnes JCM 18917
162344	C. acnes subsp. acnes JCM 18918
162348	C. acnes subsp. acnes JCM 18922
162349	C. acnes subsp. acnes JCM 18923
162350	C. acnes subsp. acnes JCM 18924
162353	C. acnes subsp. acnes JCM 18927
164457	C. acnes subsp. acnes JCM 33133
164458	C. acnes subsp. acnes JCM 33134
164459	C. acnes subsp. acnes JCM 33135
165408	C. acnes subsp. acnes JCM 6495, ATCC 11827, KCTC 5012, VPI 4979

Morphology

Cell morphology

@ref	Gram stain	Cell length	Cell width	Cell shape	Confidence
24963	positive	0.8-0.9 µm	0.4-0.5 µm	rod-shaped
24963				ellipsoidal
116031	positive			rod-shaped
125438					94
125438	positive				90.058
125439					90
125439	positive				97.2

Colony morphology

@ref	Type of hemolysis	Hemolysis ability	Colony size	Colony color	Colony shape	Medium used	Incubation period
24963	beta	1	<4.0 mm	white,tan, pink or orange			21 days
24963	beta	1	<5.0 mm	white-to-gray	circular	blood agar (horse or rabbit)
44423							2-3 days
116031

Culture and growth conditions

Culture medium

@ref	Name	Medium link	Composition
919	COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)	Medium recipe at MediaDive	Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
919	PYG MEDIUM (MODIFIED) (DSMZ Medium 104)	Medium recipe at MediaDive	Name: PYG MEDIUM (modified) (DSMZ Medium 104) Composition: Yeast extract 10.0 g/l Peptone 5.0 g/l Trypticase peptone 5.0 g/l Beef extract 5.0 g/l Glucose 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l K2HPO4 0.04 g/l KH2PO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Hemin 0.005 g/l Ethanol 0.0038 g/l Resazurin 0.001 g/l Tween 80 Vitamin K1 NaOH Distilled water
24963	blood agar (horse or rabbit)
42199	MEDIUM 20 - for Anaerobic bacteria		Agar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)
116031	CIP Medium 20	Medium recipe at CIP

Culture temp

@ref	Growth	Type	Temperature (°C)	Range
919	positive	growth	37	mesophilic
24963	positive	optimum	30.0-37.0	mesophilic
42199	positive	growth	37	mesophilic
44423	positive	growth	37	mesophilic
67770	positive	growth	37	mesophilic

Culture pH

@ref	Ability	Type	PH
24963	positive	maximum	4.5-5.0

Physiology and metabolism

Oxygen tolerance

@ref	Oxygen tolerance
919	anaerobe
24963	anaerobe
24963	aerotolerant
44423	anaerobe
116031	anaerobe

Spore formation

@ref	Spore formation	Confidence
24963
125439		97.2

Compound production

919

CompoundLL diaminopimelic acid

Murein

@ref	Murein short key	Type
919	A41.01	A3gamma LL-Dpm-Gly

Metabolite utilization

@ref	Chebi-ID	Metabolite	Utilization activity	Kind of utilization tested
24963	4853 ChEBI	esculin	-	hydrolysis
116031	4853 ChEBI	esculin	-	hydrolysis
24963	5291 ChEBI	gelatin	+	hydrolysis
24963	17234 ChEBI	glucose	+	fermentation
24963	17754 ChEBI	glycerol	+	fermentation
68380	29985 ChEBI	L-glutamate	-	degradation	from API rID32A
24963	17306 ChEBI	maltose	-	fermentation
24963	17632 ChEBI	nitrate	+	reduction
116031	17632 ChEBI	nitrate	+	reduction
116031	16301 ChEBI	nitrite	-	reduction
68380	16634 ChEBI	raffinose	-	fermentation	from API rID32A
24963	33942 ChEBI	ribose	-	fermentation
24963	30911 ChEBI	sorbitol	+	fermentation
24963	17992 ChEBI	sucrose	-	fermentation
68380	27897 ChEBI	tryptophan	+	energy source	from API rID32A
68380	16199 ChEBI	urea	-	hydrolysis	from API rID32A

Metabolite production

@ref	Chebi-ID	Metabolite
24963	35581 ChEBI	indole
68380	35581 ChEBI	indole	from API rID32A
116031	35581 ChEBI	indole

Metabolite tests

@ref	Chebi-ID	Metabolite	Indole test	Voges-proskauer-test
116031	15688 ChEBI	acetoin		-
68380	35581 ChEBI	indole	+		from API rID32A

Enzymes

@ref	Value	Activity	Ec
24963	acid phosphatase	+	3.1.3.2
68382	acid phosphatase	+	3.1.3.2	from API zym
68380	alanine arylamidase	+	3.4.11.2	from API rID32A
68382	alkaline phosphatase	-	3.1.3.1	from API zym
68380	alkaline phosphatase	-	3.1.3.1	from API rID32A
68380	alpha-arabinosidase	-	3.2.1.55	from API rID32A
68382	alpha-chymotrypsin	-	3.4.21.1	from API zym
68382	alpha-fucosidase	-	3.2.1.51	from API zym
68380	alpha-fucosidase	-	3.2.1.51	from API rID32A
68382	alpha-galactosidase	-	3.2.1.22	from API zym
68380	alpha-galactosidase	-	3.2.1.22	from API rID32A
68382	alpha-glucosidase	+	3.2.1.20	from API zym
68380	alpha-glucosidase	-	3.2.1.20	from API rID32A
68382	alpha-mannosidase	-	3.2.1.24	from API zym
116031	amylase	-
68382	beta-galactosidase	+	3.2.1.23	from API zym
116031	beta-galactosidase	-	3.2.1.23
68380	beta-Galactosidase 6-phosphate	-		from API rID32A
68382	beta-glucosidase	-	3.2.1.21	from API zym
68380	beta-glucosidase	-	3.2.1.21	from API rID32A
68382	beta-glucuronidase	-	3.2.1.31	from API zym
68380	beta-glucuronidase	-	3.2.1.31	from API rID32A
116031	caseinase	+	3.4.21.50
24963	catalase	+	1.11.1.6
116031	catalase	+	1.11.1.6
68382	cystine arylamidase	-	3.4.11.3	from API zym
116031	DNase	-
68382	esterase (C 4)	+		from API zym
68382	esterase lipase (C 8)	-		from API zym
116031	gelatinase	-
68380	glutamate decarboxylase	-	4.1.1.15	from API rID32A
68380	glutamyl-glutamate arylamidase	-		from API rID32A
68380	glycin arylamidase	+		from API rID32A
68380	histidine arylamidase	-		from API rID32A
24963	hyaluronidase	+	3.2.1.35
24963	lecithinase	+
116031	lecithinase	+
68382	leucine arylamidase	+	3.4.11.1	from API zym
68380	leucine arylamidase	-	3.4.11.1	from API rID32A
24963	lipase	+
116031	lipase	+
68382	lipase (C 14)	-		from API zym
68382	N-acetyl-beta-glucosaminidase	+	3.2.1.52	from API zym
68382	naphthol-AS-BI-phosphohydrolase	+		from API zym
24963	neuramindase	+	3.2.1.18
116031	oxidase	-
68380	phenylalanine arylamidase	-		from API rID32A
68380	proline-arylamidase	+	3.4.11.5	from API rID32A
116031	protease	-
24963	pyrrolidonyl arylamidase	+	3.4.19.3
68380	pyrrolidonyl arylamidase	-	3.4.19.3	from API rID32A
24963	ribonuclease	+	2.7.7.16
68382	trypsin	-	3.4.21.4	from API zym
68380	tryptophan deaminase	+	4.1.99.1	from API rID32A
116031	tween esterase	-
68380	tyrosine arylamidase	-		from API rID32A
116031	urease	-	3.5.1.5
68380	urease	-	3.5.1.5	from API rID32A
68382	valine arylamidase	-		from API zym

API zym

@ref	Control	Alkaline phosphatase	Esterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	Lipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	Trypsin	alpha- Chymotrypsin	Acid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	alpha- Galactosidase	beta- Galactosidase	beta- Glucuronidase	alpha- Glucosidase	beta- Glucosidase	N-acetyl-beta- glucosaminidase	alpha- Mannosidase	alpha- Fucosidase
116031	-	-	+	-	-	+	-	-	-	-	+	+	-	+	-	+	-	+	-	-

API rID32A

@ref	URE	ADH (Arg)	alpha GAL	beta GAL	beta-Galactosidase 6-phosphatebeta GP	alpha GLU	beta GLU	alpha ARA	beta GUR	beta-N-Acetyl-beta-glucosaminidasebeta NAG	MNE	RAF	GDC	alpha FUC	Reduction of nitrateNIT	IND	PAL	L-arginine arylamidaseArgA	ProA	LGA	Phenylalanine arylamidasePheA	Leucine arylamidaseLeuA	PyrA	Tyrosine arylamidaseTyrA	Alanine arylamidaseAlaA	Glycin arylamidaseGlyA	Histidine arylamidaseHisA	Glutamyl-glutamate arylamidaseGGA	Serine arylamidaseSerA
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	+/-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	-	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	-
919	-	+	-	+/-	-	-	-	-	-	+	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	-	+	-	+/-	+	-	-	-	-	-	+	+	-	-	+
919	-	-	-	+	-	-	-	-	-	+/-	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+/-	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+/-	+	-	-	-	+	+	-	+/-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	+	-	-	-	-	+	+	-	-	+

API biotype100

@ref	ControlQ	D-glucose as carbon sourceGLU	D-fructose as carbon sourceFRU	D-galactose as carbon sourceGAL	D-trehalose as carbon sourceTRE	D-mannose as carbon sourceMNE	L-sorbose as carbon sourceSBE	D-melibiose as carbon sourceMEL	sucrose as carbon sourceSAC	D-raffinose as carbon sourceRAF	maltotriose as carbon sourceMTE	maltose as carbon sourceMAL	lactose as carbon sourceLAC	lactulose as carbon sourceLTE	1-O-methyl-beta-galactopyranoside as carbon sourceMbGa	1-O-methyl-alpha-galactopyranoside as carbon sourceMaGa	D-cellobiose as carbon sourceCEL	gentiobiose as carbon sourceGEN	1-O-methyl-beta-D-glucopyranoside as carbon sourceMbGu	esculin as carbon sourceESC	D-ribose as carbon sourceRIB	L-arabinose as carbon sourceARA	D-xylose as carbon sourceXYL	palatinose as carbon sourcePLE	L-rhamnose as carbon sourceRHA	L-fucose as carbon sourceFUC	D-melezitose as carbon sourceMLZ	D-arabitol as carbon sourceDARL	L-arabitol as carbon sourceLARL	xylitol as carbon sourceXLT	dulcitol as carbon sourceDUL	D-tagatose as carbon sourceTAG	glycerol as carbon sourceGLY	myo-inositol as carbon sourceINO	D-mannitol as carbon sourceMAN	maltitol as carbon sourceMTL	D-turanose as carbon sourceTUR	D-sorbitol as carbon sourceSOR	adonitol as carbon sourceADO	hydroxyquinoline-beta-glucuronide as carbon sourceHBG	D-lyxose as carbon sourceLYX	i-erythritol as carbon sourceERY	1-O-methyl-alpha-D-glucoside as carbon sourceMDG	3-O-methyl-D-glucose as carbon source3MDG	D-saccharate as carbon sourceSAT	mucate as carbon sourceMUC	L-tartrate as carbon sourceLTAT	D-tartrate as carbon sourceDTAT	meso-tartrate as carbon sourceMTAT	D-malate as carbon sourceDMLT	L-malate as carbon sourceLMLT	cis-aconitate as carbon sourceCATE	trans-aconitate as carbon sourceTATE	tricarballylate as carbon sourceTTE	citrate as carbon sourceCIT	D-glucuronate as carbon sourceGRT	D-galacturonate as carbon sourceGAT	2-ketogluconate as carbon source2KG	5-ketogluconate as carbon source5KG	tryptophan as carbon sourceTRY	N-acetyl-D-glucosamine as carbon sourceNAG	D-gluconate as carbon sourceGNT	phenylacetate as carbon sourcePAC	protocatechuate as carbon sourcePAT	4-hydroxybenzoate as carbon sourcepOBE	quinate as carbon sourceQAT	gentisate as carbon sourceGTE	3-hydroxybenzoate as carbon sourcemOBE	benzoate as carbon sourceBAT	3-phenylpropionate as carbon sourcePPAT	m-coumarate as carbon sourceCMT	trigonelline as carbon sourceTGE	betaine as carbon sourceBET	putrescine as carbon sourcePCE	4-aminobutyrate as carbon sourceABT	histamine as carbon sourceHIN	DL-lactate as carbon sourceLAT	caprate as carbon sourceCAP	caprylate as carbon sourceCYT	L-histidine as carbon sourceHIS	succinate as carbon sourceSUC	fumarate as carbon sourceFUM	glutarate as carbon sourceGRE	DL-glycerate as carbon sourceGYT	5-aminovalerate as carbon sourceAVT	ethanolamine as carbon sourceETN	tryptamine as carbon sourceTTN	D-glucosamine as carbon sourceGLN	itaconate as carbon sourceITA	3-hydroxybutyrate as carbon source3OBU	L-aspartate as carbon sourceAPT	L-glutamate as carbon sourceGTT	L-proline as carbon sourcePRO	D-alanine as carbon sourceDALA	L-alanine as carbon sourceLALA	L-serine as carbon sourceSER	malonate as carbon sourceMNT	propionate as carbon sourcePROP	L-tyrosine as carbon sourceTYR	2-ketoglutarate as carbon source2KT
116031	not determinedn.d.	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Isolation, sampling and environmental information

Isolation source categories

Cat1	Cat2	Cat3
#Host	#Human	-
#Infection	#Inflammation	-
#Host Body-Site	#Organ	#Skin, Nail, Hair

Isolation

@ref	Sample type	Geographic location	Country	Country ISO 3 Code	Continent	Isolation date
919	acne lesion in human facial skin
24963	facial acne	London	United Kingdom	GBR	Europe
44423	Human,facial acne		United Kingdom	GBR	Europe
67770	Facial acne
116031	Facial acne	London	United Kingdom	GBR	Europe	1920

Taxonmaps

69479

Global distribution of 16S sequence AB538431 (>99% sequence identity) for Cutibacterium acnes from Microbeatlas

Aquatic Samples	7473
Soil Samples	3573
Animal Samples	47966
Plant Samples	1257
Total Samples	60269

Interaction and safety

Risk assessment

@ref	Biosafety level	Biosafety level comment
919	2	Risk group (German classification) According to TRBA 466
116031	1	Risk group (French classification) According to TRBA 466

Sequence information

Genome sequences

@ref	Description	Assembly level	INSDC accession	BV-BRC accession	IMG accession	NCBI tax ID	Score
66792	ASM673938v1 assembly for Cutibacterium acnes subsp. acnes NBRC 107605	complete	GCA_006739385	1734925.62	2888212034	1734925	98.57
66792	ASM413619v1 assembly for Cutibacterium acnes DSM 1897	complete	GCA_004136195	1122995.5	8003662419	1122995	98.48
66792	ASM303030v1 assembly for Cutibacterium acnes ATCC 6919	complete	GCA_003030305	1747.234		1747	98.07
66792	ASM872843v1 assembly for Cutibacterium acnes ATCC 6919	complete	GCA_008728435	1747.866		1747	97.88
66792	Cutibacterium acnes ATCC 6919	complete			2518285594	1747	96.69
67770	ASM47240v1 assembly for Cutibacterium acnes DSM 1897	contig	GCA_000472405	1122995.3	2515154214	1122995	76.83
66792	ASM73048v1 assembly for Cutibacterium acnes ATCC 6919	contig	GCA_000730485	1747.45	2619619216	1747	24.64

16S sequences

@ref	Description	Accession	Length	NCBI tax ID
20218	Propionibacterium acnes DNA, 16S-23S ribosomal RNA intergenic spacer region, strain: ATCC 6919	AB108459	222	1747
20218	Propionibacterium acnes ATCC 6919 16S rRNA gene, partial sequence	U02904	387	1747
20218	Propionibacterium acnes strain DSM 1897 16S ribosomal RNA gene, partial sequence	EF680378	451	1747
20218	Propionibacterium acnes partial 16S rRNA	X53218	1359	1747
20218	Propionibacterium acnes gene for 16S ribosomal RNA, partial sequence, strain: JCM 6425	AB538431	1486	1747
919	Propionibacterium acnes gene for 16S ribosomal RNA, ATCC6919	AB042288	1486	1747
124043	Propionibacterium acnes isolate IPC619 16S ribosomal RNA gene, partial sequence.	EF680379	453	33010
124043	Propionibacterium acnes isolate IPC619 16S ribosomal RNA gene, partial sequence.	EF680380	402	33011
124043	Propionibacterium acnes isolate IPC619 16S ribosomal RNA gene, partial sequence.	EF680381	403	1747
124043	Propionibacterium acnes isolate IPC619 16S ribosomal RNA gene, partial sequence.	EF680382	458	1747
124043	Cutibacterium acnes ATCC 6919 gene for 16S rRNA, partial sequence.	LC752328	1486	1747
124043	Cutibacterium acnes JCM 6425 gene for 16S rRNA, partial sequence.	LC752375	569	1747
124043	Cutibacterium acnes subsp. acnes strain DSM 1897 16S ribosomal RNA gene, partial sequence.	PP662667	1389	1734925

GC content

@ref	GC-content (mol%)	Method
919	59.0
24963	60	genome sequence analysis

Genome-based predictions

Predictions

Predictions from Deep Learning for Genome Sequence Data. R package version 0.3.1 based on: Cutibacterium acnes ATCC 6919
NCBI: GCA_003030305

@ref	Trait	Model	Prediction	Confidence in %	In training data
125439	oxygen_tolerance	BacteriaNetⓘ	microaerophile	88.30	no
125439	gram_stain	BacteriaNetⓘ	positive	97.20	no
125439	motility	BacteriaNetⓘ	no	90.00	no
125439	spore_formation	BacteriaNetⓘ	no	97.20	no

Predictions from bacterial phenotypic traits through improved machine learning using high-quality, curated datasets based on: Cutibacterium acnes ATCC 6919
NCBI: GCA_003030305.1

@ref	Trait	Model	Prediction	Confidence in %	In training data
125438	gram-positive	gram-positiveⓘ	yes	90.06	yes
125438	anaerobic	anaerobicⓘ	no	65.23	no
125438	aerobic	aerobicⓘ	no	69.89	yes
125438	spore-forming	spore-formingⓘ	no	80.92	yes
125438	thermophilic	thermophileⓘ	no	93.08	no
125438	flagellated	motile2+ⓘ	no	94.00	yes

Literature

Topic	Title	Authors	Journal	DOI	Year
	Phytochemicals, promising strategies combating Cutibacterium acnes.	Sun C, Na Y, Wang Z, Zhu T, Liu X.	Front Pharmacol	10.3389/fphar.2024.1476670	2024
	Plant Phenolics in the Prevention and Therapy of Acne: A Comprehensive Review.	Koch W, Zagorska J, Michalak-Tomczyk M, Karav S, Wawruszak A.	Molecules	10.3390/molecules29174234	2024
	Activation of Deoxyribonuclease I by Nicotinamide as a New Strategy to Attenuate Tetracycline-Resistant Biofilms of Cutibacterium acnes.	Shih YH, Liu D, Chen YC, Liao MH, Lee WR, Shen SC.	Pharmaceutics	10.3390/pharmaceutics13060819	2021
Metabolism	Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens.	O'Sullivan JN, Rea MC, O'Connor PM, Hill C, Ross RP.	FEMS Microbiol Ecol	10.1093/femsec/fiy241	2019
Metabolism	Nisin J, a Novel Natural Nisin Variant, Is Produced by Staphylococcus capitis Sourced from the Human Skin Microbiota.	O'Sullivan JN, O'Connor PM, Rea MC, O'Sullivan O, Walsh CJ, Healy B, Mathur H, Field D, Hill C, Ross RP.	J Bacteriol	10.1128/jb.00639-19	2020
	Application of bacteriocins in food preservation and infectious disease treatment for humans and livestock: a review.	Ng ZJ, Zarin MA, Lee CK, Tan JS.	RSC Adv	10.1039/d0ra06161a	2020
	Isolation of Cutibacterium acnes AP1, a rumen bacterium that forms trans-10,cis-12-conjugated linoleic acid.	Hackmann TJ, Saldivia M, Wolfe L, De Groot H, Yang J, Vahmani P.	JDS Commun	10.3168/jdsc.2024-0598	2025
	Linoleic Fatty Acid from Rwandan Propolis: A Potential Antimicrobial Agent Against Cutibacterium acnes.	Rouvier F, Abou L, Wafo E, Brunel JM.	Curr Issues Mol Biol	10.3390/cimb47030162	2025
	Comprehensive lipidomic analysis of the genus Cutibacterium.	Chudzik A, Bromke MA, Gamian A, Pasciak M.	mSphere	10.1128/msphere.00054-24	2024
	Identification of 2,4-Di-tert-Butylphenol as an Antimicrobial Agent Against Cutibacterium acnes Bacteria from Rwandan Propolis.	Rouvier F, Abou L, Wafo E, Andre P, Cheyrol J, Khacef MM, Nappez C, Lepidi H, Brunel JM.	Antibiotics (Basel)	10.3390/antibiotics13111080	2024
	Laser-assisted microbial culturomics.	Qu T, Koch L, Mukherjee R, Tu Y, Seidel AL, Puttmann LD, Winkel A, Yang I, Grischke J, Liu D, Wolkers WF, Kittler S, Chichkov B, Stiesch M, Szafranski SP.	Nat Commun	10.1038/s41467-025-66804-7	2025
	Different Cutibacterium acnes Phylotypes Release Distinct Extracellular Vesicles.	Chudzik A, Migdal P, Pasciak M.	Int J Mol Sci	10.3390/ijms23105797	2022
	First Report of Plasmid-Mediated Macrolide-Clindamycin-Tetracycline Resistance in a High Virulent Isolate of Cutibacterium acnes ST115.	Rana MS, Kim J, Kim S.	Pathogens	10.3390/pathogens12111286	2023
	The World's First Acne Dysbiosis-like Model of Human 3D Ex Vivo Sebaceous Gland Colonized with Cutibacterium acnes and Staphylococcus epidermidis.	Forraz N, Bize C, Desroches AL, Milet C, Payen P, Chanut P, Kern C, Garcia C, McGuckin C.	Microorganisms	10.3390/microorganisms11092183	2023
	Exploring the Therapeutical Potential of Asparagopsis armata Biomass: A Novel Approach for Acne Vulgaris Treatment.	Januario AP, Felix C, Felix R, Shiels K, Murray P, Valentao P, Lemos MFL.	Mar Drugs	10.3390/md22110489	2024
	Assessment of the Impact of Antimicrobial Photodynamic Therapy Using a 635 nm Diode Laser and Toluidine Blue on the Susceptibility of Selected Strains of Candida and Staphylococcus aureus: An In Vitro Study.	Tkaczyk M, Mertas A, Kuska-Kielbratowska A, Fiegler-Rudol J, Bobela E, Cisowska M, Skaba D, Wiench R.	Microorganisms	10.3390/microorganisms13092126	2025
	Gelidiales Are Not Just Agar-Revealing the Antimicrobial Potential of Gelidium corneum for Skin Disorders.	Matias M, Pinteus S, Martins A, Silva J, Alves C, Mouga T, Gaspar H, Pedrosa R.	Antibiotics (Basel)	10.3390/antibiotics11040481	2022
	A New Approach to Harness Probiotics Against Common Bacterial Skin Pathogens: Towards Living Antimicrobials.	Khalfallah G, Gartzen R, Moller M, Heine E, Lutticken R.	Probiotics Antimicrob Proteins	10.1007/s12602-021-09783-7	2021
Pathogenicity	Topical Administration of Lactiplantibacillus plantarum (SkinDuo^TM) Serum Improves Anti-Acne Properties.	Podrini C, Schramm L, Marianantoni G, Apolinarska J, McGuckin C, Forraz N, Milet C, Desroches AL, Payen P, D'Aguanno M, Biazzo M.	Microorganisms	10.3390/microorganisms11020417	2023
	Identifying and exploring biohydrogenating rumen bacteria with emphasis on pathways including trans-10 intermediates.	Dewanckele L, Jeyanathan J, Vlaeminck B, Fievez V.	BMC Microbiol	10.1186/s12866-020-01876-7	2020
	What Do We See in Spectra?: Assignment of High-Intensity Peaks of Cutibacterium and Staphylococcus Spectra of MALDI-TOF Mass Spectrometry by Interspecies Comparative Proteogenomics.	Dekio I, Sugiura Y, Hamada-Tsutsumi S, Murakami Y, Tamura H, Suematsu M.	Microorganisms	10.3390/microorganisms9061243	2021
	Saccorhiza polyschides-A Source of Natural Active Ingredients for Greener Skincare Formulations.	Susano P, Silva J, Alves C, Martins A, Pinteus S, Gaspar H, Goettert MI, Pedrosa R.	Molecules	10.3390/molecules27196496	2022
	Sugarcane Straw Hemicellulose Extraction by Autohydrolysis for Cosmetic Applications.	Pereira MJ, Pedrosa SS, Costa JR, Carvalho MJ, Neto T, Oliveira AL, Oliveira AL, Pintado M, Madureira AR.	Molecules	10.3390/molecules30061208	2025
	Microbial Reference Frames Reveal Distinct Shifts in the Skin Microbiota after Cleansing.	Sfriso R, Claypool J.	Microorganisms	10.3390/microorganisms8111634	2020
Metabolism	A New Pathway for Forming Acetate and Synthesizing ATP during Fermentation in Bacteria.	Zhang B, Lingga C, Bowman C, Hackmann TJ.	Appl Environ Microbiol	10.1128/aem.02959-20	2021
Enzymology	Unravelling the Dermatological Potential of the Brown Seaweed Carpomitra costata.	Susano P, Silva J, Alves C, Martins A, Gaspar H, Pinteus S, Mouga T, Mouga T, Goettert MI, Petrovski Z, Branco LB, Pedrosa R.	Mar Drugs	10.3390/md19030135	2021
	Elevating Skincare Science: Grape Seed Extract Encapsulation for Dermatological Care.	Castro ML, Azevedo-Silva J, Valente D, Machado A, Ribeiro T, Ferreira JP, Pintado M, Ramos OL, Borges S, Baptista-Silva S.	Molecules	10.3390/molecules29163717	2024
	Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota.	Luz-Veiga M, Amorim M, Pinto-Ribeiro I, Oliveira ALS, Silva S, Pimentel LL, Rodriguez-Alcala LM, Madureira R, Pintado M, Azevedo-Silva J, Fernandes J.	Int J Mol Sci	10.3390/ijms24032389	2023
Metabolism	Marine endophytic fungi associated with Halopteris scoparia (Linnaeus) Sauvageau as producers of bioactive secondary metabolites with potential dermocosmetic application.	Calado MDL, Silva J, Alves C, Susano P, Santos D, Alves J, Martins A, Gaspar H, Pedrosa R, Campos MJ.	PLoS One	10.1371/journal.pone.0250954	2021
	Bacteria Modify Their Sensitivity to Chemerin-Derived Peptides by Hindering Peptide Association With the Cell Surface and Peptide Oxidation.	Godlewska U, Bilska B, Majewski P, Pyza E, Zabel BA, Cichy J.	Front Microbiol	10.3389/fmicb.2020.01819	2020
	The Bacterial Life Cycle in Textiles is Governed by Fiber Hydrophobicity.	Mollebjerg A, Palmen LG, Gori K, Meyer RL.	Microbiol Spectr	10.1128/spectrum.01185-21	2021
	Highlighting the Biological Potential of the Brown Seaweed Fucus spiralis for Skin Applications.	Freitas R, Martins A, Silva J, Alves C, Pinteus S, Alves J, Teodoro F, Ribeiro HM, Goncalves L, Petrovski Z, Branco L, Pedrosa R.	Antioxidants (Basel)	10.3390/antiox9070611	2020
	Synergistic Antimicrobial Activity of Vancomycin, Ceftriaxone, and Gentamicin Against Cutibacterium acnes Strains: An In Vitro Checkerboard Analysis and In Vivo Interaction with Bioactive Glass Using Galleria mellonella.	Kurihara MNL, Brasil IF, Silva MMA, Salles MJ.	Antibiotics (Basel)	10.3390/antibiotics14090923	2025
	Synthesis, in vitro and in silico evaluation of halogenated xanthone and benzophenone derivatives as antibacterial agents against acne-causing bacteria.	Devakrishnan P, Nasir NM, Hasan H, Tejo BA, Baharuddin FF.	Bioorg Chem	10.1016/j.bioorg.2025.108906	2025
	Integrated Machine Learning and Structure-Based Virtual Screening Identifies Natural Product Targeting 50S Ribosome Inhibitory Activity Against Cutibacterium acnes.	Liu J, Tong HHY, Zheng H, Lei MIF, Li S.	Molecules	10.3390/molecules30224433	2025
	Anti-acne and anti-hyperpigmentation potential of selected South African bryophytes with identification of oleamide as a lead compound	Paulsen AQ, Seaman JL, Lall N.	S Afr J Bot		2025
	Formulation, Optimization, and Comprehensive Characterization of Topical Essential Oil-Loaded Anti-Acne Microemulgels.	Kola-Mustapha AT, Raji MA, Alzahrani YA, Binsaeed NH, Adam DR, Shameh RA, Garaween NM, Garaween G.	Gels	10.3390/gels11080612	2025
	Isolation and Antibiofilm Activity of Bacteriophages against Cutibacterium acnes from Patients with Periprosthetic Joint Infection.	Chen B, Chitto M, Tao S, Wagemans J, Lavigne R, Richards RG, Metsemakers WJ, Moriarty TF.	Viruses	10.3390/v16101592	2024
	Marine actinobacteria metabolites: unlocking new treatments for acne vulgaris.	De La Hoz-Romo MC, Diaz L, Gomez-Leon J, Quintero M, Villamil L.	Front Microbiol	10.3389/fmicb.2024.1501951	2024
Genetics	Comparative genomics analysis of six Cutibacterium acnes strains isolated from contaminated platelet concentrates.	Flint A, Kumaran D, Weedmark K, Pagotto F, Ramirez-Arcos S.	Access Microbiol	10.1099/acmi.0.000938.v3	2025
	Cutibacterium Acnes induces Alzheimer's disease-like pathology in brains of wistar rats through structural changes associated with microtubules.	Aliashrafi M, Nasehi M, Siadat SD, Mohammadi-Mahdiabadi-Hasani MH, Zali H, Niknam Z.	Behav Brain Funct	10.1186/s12993-024-00257-8	2024
	Propolis Extract with Activity Against Cutibacterium acnes Biofilm Targeting the Expression of Virulence Genes.	Athanasopoulou S, Panagiotidou E, Spanidi E, Gkika M, Georgiou D, Anagnostopoulos AK, Ganos C, Chinou I, Beletsiotis E, Gardikis K.	Antioxidants (Basel)	10.3390/antiox14070849	2025
	Topical Zinc Oxide Nanoparticle Formulations for Acne Vulgaris: A Systematic Review of Pre-Clinical and Early-Phase Clinical Evidence.	Crainic D, Popescu R, Vlad CD, Serban DV, Popa D, Popa CA, Toma AO.	Biomedicines	10.3390/biomedicines13092156	2025
	Engineered Lysin-Derived Peptide as a Potent Antimicrobial for Acne Vulgaris.	Sela U, Heselpoth RD, Fischetti VA.	Antibiotics (Basel)	10.3390/antibiotics14040344	2025
	Putative pseudolysogeny-dependent phage gene implicated in the superinfection resistance of Cutibacterium acnes.	Wottrich S, Mendonca S, Safarpour C, Nguyen C, Marinelli LJ, Hancock SP, Modlin RL, Parker JM.	Microbiome Res Rep	10.20517/mrr.2023.42	2024
	Antibacterial and Antibiofilm Properties of Postbiotics Derived from Lactiplantibacillus pentosus B1.	Nowak-Lange M, Niedzialkowska K, Tonczyk A, Parolin C, Vitali B, Lisowska K.	Int J Mol Sci	10.3390/ijms26178169	2025
	Formulation, Optimization, and Comprehensive Characterization of Topical Essential Oil-Loaded Anti-Acne Microemulgels	Kola-Mustapha A, Raji M, Alzahrani Y, Binsaeed N, Adam D, Shameh R, Garaween N, Garaween G.	Gels		2025
	Effects of Mannosylerythritol-Lipids-B on Cutibacterium acnes ATCC 6919.	Coelho ALS, Laroque DA, Feuser PE, de Andrade CJ, Carciofi BAM, de Oliveira D.	Indian J Microbiol	10.1007/s12088-023-01169-3	2024
	Antimicrobial peptides: Could cecropin A and nisin be new promising agents for the treatment of anaerobic infections.	Kurt Z, Demirci M, Ari S, Tokuc E, Kilincaslan AC, Ziyad MA, Kocazeybek BS, Tokman HB.	Pak J Pharm Sci		2024
Pathogenicity	Insights into microbial dysbiosis and Cutibacterium acnes CAMP factor interactions in acne vulgaris.	Chen Q, Liu C, Tao J, Zeng W, Zhu Z, Yao C, Shang Y, Tang J, Jin T.	Microb Genom	10.1099/mgen.0.001449	2025
Genetics	Whole genome sequencing distinguishes skin colonizing from infection-associated Cutibacterium acnes isolates.	Podbielski A, Koller T, Warnke P, Barrantes I, Kreikemeyer B.	Front Cell Infect Microbiol	10.3389/fcimb.2024.1433783	2024
	Antioxidant Activities of the Cell-Free Supernatant of a Potential Probiotic Cutibacterium acnes Strain CCSM0331, Isolated From a Healthy Skin.	Shao L, Huang J, Li Y, Ma L, Niu Y, Jiang W, Yuan C, Bai T, Yang S.	J Cosmet Dermatol	10.1111/jocd.70105	2025
	Heat-treated Pediococcus acidilactici LM1013-mediated inhibition of biofilm formation by Cutibacterium acnes and its application in acne vulgaris: A single-arm clinical trial.	Bae WY, Jung WH, Lee YJ, Shin SL, An YK, Kim TR, Sohn M.	J Cosmet Dermatol	10.1111/jocd.15809	2023
	Can Gentisic Acid Serve as a High-Performance Antioxidant with Lower Toxicity for a Promising New Topical Application?	Cunha LB, Lepore ED, Medeiros CCB, Sorrechia R, Pietro RCLR, Correa MA.	Life (Basel)	10.3390/life14081022	2024
	Cutibacterium acnes lysate improves cellular response against Candida albicans, Escherichia coli and Gardnerella vaginalis in an in vitro model of vaginal infection.	Ricchi F, Kenno S, Pedretti N, Brenna G, De Seta F, Ardizzoni A, Pericolini E.	Front Cell Infect Microbiol	10.3389/fcimb.2025.1578831	2025
Phylogeny	A multiphasic approach to solve misidentification of Cutibacterium acnes as Atopobium vaginae during routine bacterial screening of platelet concentrates using the VITEK 2 system.	Kumaran D, Laflamme C, Ramirez-Arcos S.	Access Microbiol	10.1099/acmi.0.000539.v3	2023
Pathogenicity	Biological Evaluation of the Antibacterial Retinoid CD437 in Cutibacterium acnes Infection.	Huang XW, Pan W, Zhong MZ, Chhonker YS, Steele AD, Keohane CE, Mishra B, Felix Raj Lucas LO, Murry DJ, Ausubel FM, Wuest WM, Li CX, Mylonakis E.	Antimicrob Agents Chemother	10.1128/aac.01679-22	2023
Pathogenicity	Berberine Inhibits Acne-Related Lipid Secretion and Inflammation by Regulating the hsa-miR-3150a-3p/TP53 Pathway.	Li T, Yang X, Wang X, Xu S.	J Inflamm Res	10.2147/jir.s526923	2025
	Antimicrobial effects of blue light therapy against cutibacterium acnes: optimal dosing and impact of serial treatments.	Cotter EJ, Cotter LM, Riley CN, Dixon J, VanDerwerker N, Ufot AI, Godfrey J, Gold D, Hetzel SJ, Safdar N, Grogan BF.	JSES Int	10.1016/j.jseint.2023.11.020	2024
	Facultatively Anaerobic Staphylococci Enable Anaerobic Cutibacterium Species to Grow and Form Biofilms Under Aerobic Conditions.	Kaplan JB, Assa M, Mruwat N, Sailer M, Regmi S, Kridin K.	Microorganisms	10.3390/microorganisms12122601	2024
	vB_CacS-HV1 as a Novel Pahexavirus Bacteriophage with Lytic and Anti-Biofilm Potential against Cutibacterium acnes.	Li X, Ding W, Li Z, Yan Y, Tong Y, Xu J, Li M.	Microorganisms	10.3390/microorganisms12081566	2024
	Microemulsion-based topical hydrogels containing lemongrass leaf essential oil (Cymbopogon citratus (DC.) Stapf) and mango seed kernel extract (Mangifera indica Linn) for acne treatment: Preparation and in-vitro evaluations.	Nguyen NNT, Nguyen TTD, Vo DL, Than DTM, Tien GP, Pham DT.	PLoS One	10.1371/journal.pone.0312841	2024
	Evaluation of the antibacterial efficacy of combinations of Garcinia mangostana, Curcuma comosa, and Acanthus ebracteatus for acne vulgaris treatment: in Silico and in vitro validation.	Eawsakul K, Bunluepuech K, Wisessombat S.	BMC Complement Med Ther	10.1186/s12906-025-04997-6	2025
	Sebum Components Dampen the Efficacy of Skin Disinfectants against Cutibacterium acnes Biofilms.	Kumaran D, Ramirez-Arcos S.	Microorganisms	10.3390/microorganisms12020271	2024
	Emulgel Containing Metronidazole and Clindamycin for the Treatment of Rosacea.	De Grau-Bassal G, Calpena-Campmany AC, Silva-Abreu M, Suner-Carbo J, Mallandrich-Miret M, Martinez-Ruiz S, Cordero C, Del Pozo A, Febrer NB.	Pharmaceutics	10.3390/pharmaceutics17020168	2025
	Next-generation Sequencing Results Require Higher Inoculum for Cutibacterium acnes Detection Than Conventional Anaerobic Culture.	Fernandez-Rodriguez D, Cho J, Parvizi N, Khan AZ, Parvizi J, Namdari S.	Clin Orthop Relat Res	10.1097/corr.0000000000002738	2023
	Bacterial Cellulose as a UVB Filter to Protect the Skin Microbiota.	Alarcon-Guijo P, Garces V, Gonzalez A, Delgado-Lopez JM, Ullah R, Bansal V, Dominguez-Vera JM.	Macromol Biosci	10.1002/mabi.202400269	2025
	Antibacterial efficacy of low-dosage silver nanoparticle-sodium alginate-chitosan nanocomposite films against pure and clinical acne strains.	Thai Tran BL, Van Vo T, Chu TP, Bach DT, Nguyen TQ, Bao Luu PH, Thuy Tran VT, Duong HH, Nguyen NH, Le GT, Tran TT, Tuong Tran KN, Cam Tuyen LT, Dinh TN, Uyen NN, Thu Nguyen TT, Thi Nguyen NV, Nguyen KT, Nhu Tran LT, Le PH.	RSC Adv	10.1039/d4ra05180g	2024
	Anti-Inflammatory and Anti-Quorum Sensing Effect of Camellia sinensis Callus Lysate for Treatment of Acne.	Canellas-Santos M, Rosell-Vives E, Montell L, Bilbao A, Goni-de-Cerio F, Fernandez-Campos F.	Curr Issues Mol Biol	10.3390/cimb45050255	2023
	Recent evidence on prominent anti-bacterial capacities of compounds derived from the mangosteen fruit.	Eiselt VA, Bereswill S, Heimesaat MM.	Eur J Microbiol Immunol (Bp)	10.1556/1886.2025.00006	2025
Enzymology	Study on Oleum cinnamomi Inhibiting Cutibacterium acnes and Its Covalent Inhibition Mechanism.	Peng H, Chu C, Jin L, Zhang J, Yang Z, Zhu L, Yang D, Zhao Z.	Molecules	10.3390/molecules29133165	2024
	Inhibition of Biofilm Formation in Cutibacterium acnes, Staphylococcus aureus, and Candida albicans by the Phytopigment Shikonin.	Kim YG, Lee JH, Kim SH, Park SY, Kim YJ, Ryu CM, Seo HW, Lee JT.	Int J Mol Sci	10.3390/ijms25042426	2024
	Nasturtium officinale Microshoot Culture Multiplied in PlantForm Bioreactor-Phytochemical Profiling and Biological Activity.	Klimek-Szczykutowicz M, Malinowska MA, Galka A, Blazevic I, Dulovic A, Paprocka P, Wrzosek M, Szopa A.	Molecules	10.3390/molecules30040936	2025
	Photodynamic Effects of Topical Photosensitizer, Photodithazine Using Micro-LED for Acne Bacteria Induced Inflammation.	Lee SM, Kim SH, Kim Z, Lee JB.	Ann Dermatol	10.5021/ad.23.157	2024
	Assessment of the Anti-Acne Properties of Some Medicinal Plants and Development of an Herbal Anti-Acne Formulation.	Deniz FSS, Oyardi O, Bozkurt Guzel C, Yalcin TE, Yigitkan S, Kan Y, Ulger Toprak N, Orhan IE.	Pharmaceutics	10.3390/pharmaceutics17030317	2025
	The Assessment of Physicochemical and Antimicrobial Properties of Hydrophilic Gels Containing Tetracycline Hydrochloride and Various Concentrations of Ethanol	Kostrzebska A, Junka A, Brozyna M, Musial W.	Pharmaceutics		2024
	Biodegradable sustained-release microneedle patch loaded with clindamycin hydrochloride: a breakthrough in acne management.	Fan H, Liao R, Yang Y, Xing Y, Zhang C, Luo X, Pu C, Wu L, Li X, Zhao J, Xiao D.	Front Pharmacol	10.3389/fphar.2025.1575635	2025
	Nonpathogenic Cutibacterium acnes Confers Host Resistance against Staphylococcus aureus.	Tsuru A, Hamazaki Y, Tomida S, Ali MS, Komura T, Nishikawa Y, Kage-Nakadai E.	Microbiol Spectr	10.1128/spectrum.00562-21	2021
Pathogenicity	Cutibacterium acnes strains associated with bone prosthesis infections cannot evade the host immune system.	Thoraval L, Tang-Fichaux M, Guillaume C, Varin-Simon J, Dumortier C, Sergheraert J, Lamret F, Bonhomme M, Laurent F, Josse J, Gangloff SC, Mongaret C, Reffuveille F, Velard F.	Front Immunol	10.3389/fimmu.2024.1468709	2024
	Phytopigment Alizarin Inhibits Multispecies Biofilm Development by Cutibacterium acnes, Staphylococcus aureus, and Candida albicans.	Lee JH, Kim YG, Park S, Hu L, Lee J.	Pharmaceutics	10.3390/pharmaceutics14051047	2022
Genetics	Genomics of Invasive Cutibacterium acnes Isolates from Deep-Seated Infections.	Both A, Huang J, Hentschke M, Tobys D, Christner M, Klatte TO, Seifert H, Aepfelbacher M, Rohde H.	Microbiol Spectr	10.1128/spectrum.04740-22	2023
	The Activity of Gold Nanoparticles Synthesized Using Helichrysum odoratissimum Against Cutibacterium acnes Biofilms.	De Canha MN, Thipe VC, Katti KV, Mandiwana V, Kalombo ML, Ray SS, Rikhotso R, Janse van Vuuren A, Lall N.	Front Cell Dev Biol	10.3389/fcell.2021.675064	2021
	Commercially Available Viola odorata Oil, Chemical Variability and Antimicrobial Activity.	Orchard A, Moosa T, Motala N, Kamatou G, Viljoen A, Vuuren SV.	Molecules	10.3390/molecules28041676	2023
	Antimicrobial Properties Related to Anti-Acne and Deodorant Efficacy of Hedychium coronarium J. Koenig Extracts from Pulsed Electric Field Extraction.	Mitchaleaw M, Juntrapirom S, Bunrod A, Kanjanakawinkul W, Yawootti A, Charoensup W, Sirilun S, Chaiyana W.	Antibiotics (Basel)	10.3390/antibiotics13010108	2024
Pathogenicity	Efficacy of FRO on Acne Vulgaris Pathogenesis.	Kim JE, Han H, Xu Y, Lee MH, Lee HJ.	Pharmaceutics	10.3390/pharmaceutics15071885	2023
	Preventing bacterial adhesion to skin by altering their physicochemical cell surface properties specifically.	Janvier X, Jansen S, Prenom C, Khodabux N, Zuttion F, Duclairoir-Poc C, Cupferman S, Khodr A.	NPJ Biofilms Microbiomes	10.1038/s41522-024-00568-8	2024
	A pilot study on the efficacy of topical lotion containing anti-acne postbiotic in subjects with mild -to -moderate acne.	Cui H, Guo C, Wang Q, Feng C, Duan Z.	Front Med (Lausanne)	10.3389/fmed.2022.1064460	2022
	New Insights into Cutaneous Asepsis: Synergism between Pfaffia and Rosemary Extracts.	Miranda DG, Carrouel F, Silva TCA, Rozzatto MC, Hasna AA, Santos CER, Morais FV, de Oliveira LD, de Paula Ramos L.	Antibiotics (Basel)	10.3390/antibiotics13030226	2024
Pathogenicity	Potential of cannabidiol as acne and acne scar treatment: novel insights into molecular pathways of pathophysiological factors.	Lee JH, Yoon JY, Kim DH, Kwon YG, Kim GH, Park BJ, Suh DH.	Arch Dermatol Res	10.1007/s00403-024-03131-9	2024
	Emodin exhibits anti-acne potential by inhibiting cell growth, lipogenesis, and inflammation in human SZ95 sebocytes.	Liu S, Luo XH, Liu YF, Zouboulis CC, Shi G.	Sci Rep	10.1038/s41598-023-48709-x	2023
	The Effect of Cutibacterium acnes Infection on Nerve Penetration in the Annulus Fibrosus of Lumbar Intervertebral Discs via Suppressing Oxidative Stress.	Shan Z, Wang X, Zong W, Li J, Zheng B, Huang B, Zhang X, Chen J, Huang Y.	Oxid Med Cell Longev	10.1155/2022/9120674	2022
	Development of Novel Topical Anti-Acne Cream Containing Postbiotics for Mild-to-Moderate Acne: An Observational Study to Evaluate Its Efficacy.	Cui H, Feng C, Guo C, Duan Z.	Indian J Dermatol	10.4103/ijd.ijd_655_22	2022
Pathogenicity	Electricity-producing Staphylococcus epidermidis counteracts Cutibacterium acnes.	Marito S, Keshari S, Traisaeng S, My DTT, Balasubramaniam A, Adi P, Hsieh MF, Herr DR, Huang CM.	Sci Rep	10.1038/s41598-021-91398-7	2021
	Multidrug Resistance Plasmid pTZC1 Could Be Pooled among Cutibacterium Strains on the Skin Surface.	Koizumi J, Nakase K, Hayashi N, Takeo C, Nakaminami H.	Microbiol Spectr	10.1128/spectrum.03628-22	2023
	Innovative Alkanediol-Based Eutectic Solvents for Extracting/Pre-Formulating Dermatologically Valuable Free Fatty Acids from Spirulina and Porphyridium Cakes.	Wils L, Yagmur M, Bellin N, Phelippe M, Chevalley A, Bodet C, Boudesocque-Delaye L.	Mar Drugs	10.3390/md22060281	2024
	Antimicrobial, Antioxidant and Cytotoxic Effects of Essential Oil, Fatty Acids and Bioactive Compounds of Beta vulgaris var. crassa (Fodder Beet).	Zongur A.	Indian J Microbiol	10.1007/s12088-024-01269-8	2024
	In Vitro Evaluation of Photodynamic Activity of Plant Extracts from Senna Species against Microorganisms of Medical and Dental Interest.	Oliveira AB, Ferrisse TM, Annunzio SR, Franca MGA, Silva MGV, Cavalheiro AJ, Fontana CR, Brighenti FL.	Pharmaceutics	10.3390/pharmaceutics15010181	2023
	Antibacterial Activity of the Essential Oil From Litsea cubeba Against Cutibacterium acnes and the Investigations of Its Potential Mechanism by Gas Chromatography-Mass Spectrometry Metabolomics.	Chen J, Zhang J, Zhu L, Qian C, Tian H, Zhao Z, Jin L, Yang D.	Front Microbiol	10.3389/fmicb.2022.823845	2022
	Circulating Antibodies to Skin Bacteria Detected by Serological Lateral Flow Immunoassays Differentially Correlated With Bacterial Abundance.	Huang RY, Lee CN, Moochhala S.	Front Microbiol	10.3389/fmicb.2021.709562	2021
	Microecology in vitro model replicates the human skin microbiome interactions.	Wang P, Li H, Zhang X, Wang X, Sun W, Zhang X, Chi B, Go Y, Chan XHF, Wu J, Huang Q.	Nat Commun	10.1038/s41467-025-58377-2	2025
	D-optimal mixture design for optimization of topical dapsone niosomes: in vitro characterization and in vivo activity against Cutibacterium acnes.	Habib BA, Abdeltawab NF, Salah Ad-Din I.	Drug Deliv	10.1080/10717544.2022.2048131	2022
Metabolism	PEG-8 Laurate Fermentation of Staphylococcus epidermidis Reduces the Required Dose of Clindamycin Against Cutibacterium acnes.	Marito S, Keshari S, Huang CM.	Int J Mol Sci	10.3390/ijms21145103	2020
	Antimicrobial Susceptibility, Biotypes and Phylotypes of Clinical Cutibacterium (Formerly Propionibacterium) acnes Strains Isolated from Acne Patients: An Observational Study.	Zhang N, Yuan R, Xin KZ, Lu Z, Ma Y.	Dermatol Ther (Heidelb)	10.1007/s13555-019-00320-7	2019
	Different phylotypes of Cutibacterium acnes cause different modic changes in intervertebral disc degeneration.	Lan W, Wang X, Tu X, Hu X, Lu H.	PLoS One	10.1371/journal.pone.0270982	2022
Pathogenicity	Zinc(II) Complexes of Amino Acids as New Active Ingredients for Anti-Acne Dermatological Preparations.	Abendrot M, Pluciennik E, Felczak A, Zawadzka K, Piatczak E, Nowaczyk P, Kalinowska-Lis U.	Int J Mol Sci	10.3390/ijms22041641	2021
Pathogenicity	Cutibacterium acnes Biofilm Study during Bone Cells Interaction.	Mongaret C, Varin-Simon J, Lamret F, El-Mahdy TS, Brasme L, Vernet-Garnier V, Gangloff SC, Ohl X, Reffuveille F.	Microorganisms	10.3390/microorganisms8091409	2020
	Antibacterial Activity of 2-Hydroxyisocaproic Acid (HICA) Against Obligate Anaerobic Bacterial Species Associated With Periodontal Disease.	Sakko M, Rautemaa-Richardson R, Sakko S, Richardson M, Sorsa T.	Microbiol Insights	10.1177/11786361211050086	2021
Enzymology	Propanediol (and) Caprylic Acid (and) Xylitol as a New Single Topical Active Ingredient against Acne: In Vitro and In Vivo Efficacy Assays.	Mussi L, Baby AR, Camargo Junior FB, Padovani G, Sufi BDS, Magalhaes WV.	Molecules	10.3390/molecules26216704	2021
	Harnessing the Power of Alchemilla: A Natural Solution for Skin Health and Dermatological Disorders.	Kanak S, Krzeminska B, Berecka-Rycerz A, Kopec M, Dos Santos Szewczyk K.	Molecules	10.3390/molecules30081861	2025
	Machine learning-based detection of adventitious microbes in T-cell therapy cultures using long-read sequencing.	Strutt JPB, Natarajan M, Lee E, Teo DBL, Sin WX, Cheung KW, Chew M, Thazin K, Barone PW, Wolfrum JM, Williams RBH, Rice SA, Springs SL.	Microbiol Spectr	10.1128/spectrum.01350-23	2023
Pathogenicity	Characterization of Weissella viridescens UCO-SMC3 as a Potential Probiotic for the Skin: Its Beneficial Role in the Pathogenesis of Acne Vulgaris.	Espinoza-Monje M, Campos J, Alvarez Villamil E, Jerez A, Dentice Maidana S, Elean M, Salva S, Kitazawa H, Villena J, Garcia-Cancino A.	Microorganisms	10.3390/microorganisms9071486	2021
	Exploring the Antimicrobial Properties of 99 Natural Flavour and Fragrance Raw Materials against Pathogenic Bacteria: A Comparative Study with Antibiotics.	Bacinska Z, Baberowska K, Surowiak AK, Balcerzak L, Strub DJ.	Plants (Basel)	10.3390/plants12213777	2023
	Staphylococcus epidermidis and Cutibacterium acnes: Two Major Sentinels of Skin Microbiota and the Influence of Cosmetics.	Fourniere M, Latire T, Souak D, Feuilloley MGJ, Bedoux G.	Microorganisms	10.3390/microorganisms8111752	2020
	Bee Venom and Its Major Component Melittin Attenuated Cutibacterium acnes- and IGF-1-Induced Acne Vulgaris via Inactivation of Akt/mTOR/SREBP Signaling Pathway.	Gu H, An HJ, Gwon MG, Bae S, Leem J, Lee SJ, Han SM, Zouboulis CC, Park KK.	Int J Mol Sci	10.3390/ijms23063152	2022
	In Vitro and In Silico Pharmacological and Cosmeceutical Potential of Ten Essential Oils from Aromatic Medicinal Plants from the Mascarene Islands.	Jugreet BS, Lall N, Anina Lambrechts I, Reid AM, Maphutha J, Nel M, Hassan AH, Khalid A, Abdalla AN, Van BL, Mahomoodally MF.	Molecules	10.3390/molecules27248705	2022
	Development and metabolic profiling of a postbiotic complex exhibiting antibacterial activity against skin microorganisms and anti-inflammatory effect on human keratinocytes.	Chung HJ, Lee H, Kim M, Lee JW, Saeed M, Lee H, Jung SH, Shim JJ, Lee JL, Heo K, Choi HK.	Food Sci Biotechnol	10.1007/s10068-022-01123-x	2022
	In Vitro Evaluation of Common Antimicrobial Solutions Used for Breast Implant Soaking and Breast Pocket Irrigation-Part 1: Efficacy Against Planktonic Bacteria.	Jewell ML, Hariri S, Lantz EE, Jewell HL, Strickland AD, Leung BK.	Aesthet Surg J	10.1093/asj/sjaa309	2021
Genetics	Transferable Multidrug-Resistance Plasmid Carrying a Novel Macrolide-Clindamycin Resistance Gene, erm(50), in Cutibacterium acnes.	Aoki S, Nakase K, Nakaminami H, Wajima T, Hayashi N, Noguchi N.	Antimicrob Agents Chemother	10.1128/aac.01810-19	2020
	Untargeted Lipidomics Analysis to Discover Lipid Profiles and Biomarkers of Rabbit Acne Model and Reveal Action Mechanism of Isotretinoin.	Wu L, Zhu Y, Zhu S, Zhang D, Wang X, Xiao Z, Tan Y, Ouyang X, Li C.	Drug Des Devel Ther	10.2147/dddt.s476649	2024
	Evaluation of the Antioxidant and Antimicrobial Activities of Ethyl Acetate Extract of Saccharomyces cerevisiae.	Makky EA, AlMatar M, Mahmood MH, Ting OW, Qi WZ.	Food Technol Biotechnol	10.17113/ftb.59.02.21.6658	2021
	Wireless Intelligent Patch for Closed-loop In Situ Wound Management.	Liu Z, Song H, Lin G, Zhong W, Zhang Y, Yang A, Liu Y, Duan J, Zhou Y, Jiao K, Ding D, Feng Y, Yue J, Zhao W, Lin X.	Adv Sci (Weinh)	10.1002/advs.202400451	2024
	Molecular detection of Propionibacterium acnes in biopsy samples of intervertebral disc with modic changes in patients undergoing herniated disc surgery.	Najafi S, Mahmoudi P, Bassampour SA, Shekarchi B, Soleimani M, Mohammadimehr M.	Iran J Microbiol	10.18502/ijm.v12i6.5025	2020
Pathogenicity	The Anticancer Agent 3,3'-Diindolylmethane Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and Candida albicans.	Kim YG, Lee JH, Park S, Lee J.	Microbiol Spectr	10.1128/spectrum.02056-21	2022
	In Vitro Evaluation of Common Antimicrobial Solutions Used for Breast Implant Soaking and Breast Pocket Irrigation-Part 2: Efficacy Against Biofilm-Associated Bacteria.	Jewell ML, Bionda N, Moran AV, Bevels EJ, Jewell HL, Hariri S, Leung BK.	Aesthet Surg J	10.1093/asj/sjaa308	2021
	Novel Dietary Approach with Probiotics, Prebiotics, and Synbiotics to Mitigate Antimicrobial Resistance and Subsequent Out Marketplace of Antimicrobial Agents: A Review.	Habteweld HA, Asfaw T.	Infect Drug Resist	10.2147/idr.s413416	2023
Pathogenicity	Antibacterial and Anti-Inflammatory Activities of Thymus vulgaris Essential Oil Nanoemulsion on Acne Vulgaris.	Abdelhamed FM, Abdeltawab NF, ElRakaiby MT, Shamma RN, Moneib NA.	Microorganisms	10.3390/microorganisms10091874	2022
Metabolism	Propionic acid produced by Cutibacterium acnes fermentation ameliorates ultraviolet B-induced melanin synthesis.	Kao HJ, Wang YH, Keshari S, Yang JJ, Simbolon S, Chen CC, Huang CM.	Sci Rep	10.1038/s41598-021-91386-x	2021
	Extracellular electrons transferred from honey probiotic Bacillus circulans inhibits inflammatory acne vulgaris.	Kao HJ, Balasubramaniam A, Chen CC, Huang CM.	Sci Rep	10.1038/s41598-022-23848-9	2022
	A Novel Truncated CHAP Modular Endolysin, CHAP^SAP26-161, That Lyses Staphylococcus aureus, Acinetobacter baumannii, and Clostridioides difficile, and Exhibits Therapeutic Effects in a Mouse Model of A. baumannii Infection.	Choi YJ, Kim S, Dahal RH, Kim J.	J Microbiol Biotechnol	10.4014/jmb.2402.02042	2024
	A Microtube Array Membrane (MTAM) Encapsulated Live Fermenting Staphylococcus epidermidis as a Skin Probiotic Patch against Cutibacterium acnes.	Yang AJ, Marito S, Yang JJ, Keshari S, Chew CH, Chen CC, Huang CM.	Int J Mol Sci	10.3390/ijms20010014	2018
Genetics	Cutibacterium acnes (Propionibacterium acnes) 16S rRNA Genotyping of Microbial Samples from Possessions Contributes to Owner Identification.	Yang J, Tsukimi T, Yoshikawa M, Suzuki K, Takeda T, Tomita M, Fukuda S.	mSystems	10.1128/msystems.00594-19	2019
	Bactericidal efficacy of hydrogen peroxide on Cutibacterium acnes.	Hernandez P, Sager B, Fa A, Liang T, Lozano C, Khazzam M.	Bone Joint Res	10.1302/2046-3758.81.bjr-2018-0145.r1	2019
Pathogenicity	In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria.	Blaskovich MAT, Elliott AG, Kavanagh AM, Ramu S, Cooper MA.	Sci Rep	10.1038/s41598-019-50746-4	2019
	Cosmeceutical application of extracts from the flowers, stems, and leaves of Buddleja davidii grown at different altitudes.	Chen CY, Wang GH, Chang YC, Liu S, Lin YT, Lai YL, Chung YC.	Front Pharmacol	10.3389/fphar.2025.1551134	2025
	Validation of Microbiological Testing of Tissue Preparations with Different Incubation Temperatures.	Herrlinger F, Schulz T, Pruss A, Schulz E.	Transfus Med Hemother	10.1159/000513646	2021
	Head and neck dermatitis is exacerbated by Malassezia furfur colonization, skin barrier disruption, and immune dysregulation.	Chu H, Kim SM, Zhang K, Wu Z, Lee H, Kim JH, Kim HL, Kim YR, Kim SH, Kim WJ, Lee YW, Lee KH, Liu KH, Park CO.	Front Immunol	10.3389/fimmu.2023.1114321	2023
	Induction of cervical disc degeneration and discogenic pain by low concentration Propionibacterium acnes infection: an in vivo animal study.	Li J, Li H, Chen Y, Bei D, Huang B, Gan K, Sang P, Liu J, Shan Z, Chen J, Zhao F, Chen B.	Arthritis Res Ther	10.1186/s13075-024-03269-x	2024
	Synthesis and Characterization of New Multifunctional Self-Boosted Filters for UV Protection: ZnO Complex with Dihydroxyphenyl Benzimidazole Carboxylic Acid.	Battistin M, Durini E, Dissette V, Bonetto A, Marcomini A, Casagrande E, Brunetta A, Ziosi P, Molesini S, Gavioli R, Nicoli F, Manfredini S, Vertuani S, Baldisserotto A.	Molecules	10.3390/molecules24244546	2019
	Mrgprb2-mediated mast cell activation exacerbates Modic changes by regulating immune niches.	Ji Z, Li J, Tao S, Li H, Kong X, Huang B, Feng Z, Wei X, Zheng Z, Chen J, Chen B, Liu J, Zhao F.	Exp Mol Med	10.1038/s12276-024-01230-1	2024
	Application of Microwave-Assisted Water Extraction (MAWE) to Fully Realize Various Physiological Activities of Melaleuca quinquenervia Leaf Extract.	Lin TK, Leu JY, Lai YL, Chang YC, Chung YC, Liu HW.	Plants (Basel)	10.3390/plants13233362	2024
Pathogenicity	Biofilm-derived oxylipin 10-HOME-mediated immune response in women with breast implants.	Khan I, Minto RE, Kelley-Patteson C, Singh K, Timsina L, Suh LJ, Rinne E, Van Natta BW, Neumann CR, Mohan G, Lester M, VonDerHaar RJ, German R, Marino N, Hassanein AH, Gordillo GM, Kaplan MH, Sen CK, Kadin ME, Sinha M.	J Clin Invest	10.1172/jci165644	2023
	Staphylococcus saccharolyticus: An Overlooked Human Skin Colonizer.	Ahle CM, Stodkilde K, Afshar M, Poehlein A, Ogilvie LA, Soderquist B, Hupeden J, Bruggemann H.	Microorganisms	10.3390/microorganisms8081105	2020
Genetics	Red-Brown Pigmentation of Acidipropionibacterium jensenii Is Tied to Haemolytic Activity and cyl-Like Gene Cluster.	Deptula P, Loivamaa I, Smolander OP, Laine P, Roberts RJ, Piironen V, Paulin L, Savijoki K, Auvinen P, Varmanen P.	Microorganisms	10.3390/microorganisms7110512	2019
	Identification and Functional Analysis of Cytokine-Like Protein CLEC-47 in Caenorhabditis elegans.	Pan W, Huang X, Guo Z, Nagarajan R, Mylonakis E.	mBio	10.1128/mbio.02579-21	2021
	Amplicon-based sequencing and co-occurence network analysis reveals notable differences of microbial community structure in healthy and dandruff scalps.	Wang L, Yu T, Zhu Y, Luo Y, Dong F, Lin X, Zhao W, He Z, Hu S, Dong Z.	BMC Genomics	10.1186/s12864-022-08534-4	2022
	The Antimicrobial Effect of Various Single-Strain and Multi-Strain Probiotics, Dietary Supplements or Other Beneficial Microbes against Common Clinical Wound Pathogens.	Fijan S, Kocbek P, Steyer A, Vodicar PM, Strauss M.	Microorganisms	10.3390/microorganisms10122518	2022
Pathogenicity	Novel methodologies for host-microbe interactions and microbiome-targeted therapeutics in 3D organotypic skin models.	Rikken G, Meesters LD, Jansen PAM, Rodijk-Olthuis D, van Vlijmen-Willems IMJJ, Niehues H, Smits JPH, Olah P, Homey B, Schalkwijk J, Zeeuwen PLJM, van den Bogaard EH.	Microbiome	10.1186/s40168-023-01668-x	2023
	Laboratory Grown Biofilms of Bacteria Associated with Human Atherosclerotic Carotid Arteries Release Collagenases and Gelatinases during Iron-Induced Dispersion.	Zdimal AM, Davies DG.	Microbiol Spectr	10.1128/spectrum.01001-21	2022
	Sideritis Perfoliata (Subsp. Perfoliata) Nutritive Value and Its Potential Medicinal Properties.	Lall N, Chrysargyris A, Lambrechts I, Fibrich B, Blom Van Staden A, Twilley D, de Canha MN, Oosthuizen CB, Bodiba D, Tzortzakis N.	Antioxidants (Basel)	10.3390/antiox8110521	2019
Pathogenicity	Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris.	Lesiak A, Paprocka P, Wnorowska U, Mankowska A, Krol G, Gluszek K, Piktel E, Spalek J, Okla S, Fiedoruk K, Durnas B, Bucki R.	Front Immunol	10.3389/fimmu.2024.1502242	2024
	Candida auris Direct Detection from Surveillance Swabs, Blood, and Urine Using a Laboratory-Developed PCR Method.	Walchak RC, Buckwalter SP, Zinsmaster NM, Henn KM, Johnson KM, Koelsch JM, Herring SA, Steinmetz LK, Reed KA, Barth JE, Rasmusson JM, Fischer JL, Snippes Vagnone P, Sampathkumar P, Wengenack NL.	J Fungi (Basel)	10.3390/jof6040224	2020
	The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics.	Hong H, Sloan L, Saxena D, Scott DA.	Biomedicines	10.3390/biomedicines10081959	2022
	Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria.	Eckman E, Laman JD, Fischer KF, Lopansri B, Martins TB, Hill HR, Kriesel JD.	J Mol Med (Berl)	10.1007/s00109-021-02085-z	2021
	The Effects of Synthetic SREBP-1 and PPAR-gamma Decoy Oligodeoxynucleotide on Acne-like Disease In Vivo and In Vitro via Lipogenic Regulation.	Gu H, An HJ, Gwon MG, Bae S, Zouboulis CC, Park KK.	Biomolecules	10.3390/biom12121858	2022
	The Lactobacillus as a Probiotic: Focusing on Liver Diseases.	Jeong JJ, Park HJ, Cha MG, Park E, Won SM, Ganesan R, Gupta H, Gebru YA, Sharma SP, Lee SB, Kwon GH, Jeong MK, Min BH, Hyun JY, Eom JA, Yoon SJ, Choi MR, Kim DJ, Suk KT.	Microorganisms	10.3390/microorganisms10020288	2022
	Prebiotic Colloidal Oat Supports the Growth of Cutaneous Commensal Bacteria Including S. epidermidis and Enhances the Production of Lactic Acid.	Liu-Walsh F, Tierney NK, Hauschild J, Rush AK, Masucci J, Leo GC, Capone KA.	Clin Cosmet Investig Dermatol	10.2147/ccid.s253386	2021
	Ozonated Sunflower Oil Exerted Protective Effect for Embryo and Cell Survival via Potent Reduction Power and Antioxidant Activity in HDL with Strong Antimicrobial Activity.	Cho KH, Kang DJ, Nam HS, Kim JH, Kim SY, Lee JO, Kim BJ.	Antioxidants (Basel)	10.3390/antiox10111651	2021
Pathogenicity	Type I IFNs link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosacea.	Mylonas A, Hawerkamp HC, Wang Y, Chen J, Messina F, Demaria O, Meller S, Homey B, Di Domizio J, Mazzolai L, Hovnanian A, Gilliet M, Conrad C.	JCI Insight	10.1172/jci.insight.151846	2023
Genetics	Characterization of metagenome-assembled genomes from the International Space Station.	Singh NK, Wood JM, Patane J, Moura LMS, Lombardino J, Setubal JC, Venkateswaran K.	Microbiome	10.1186/s40168-023-01545-7	2023
Pathogenicity	Bacterial Indole as a Multifunctional Regulator of Klebsiella oxytoca Complex Enterotoxicity.	Ledala N, Malik M, Rezaul K, Paveglio S, Provatas A, Kiel A, Caimano M, Zhou Y, Lindgren J, Krasulova K, Illes P, Dvorak Z, Kortagere S, Kienesberger S, Cosic A, Poltl L, Zechner EL, Ghosh S, Mani S, Radolf JD, Matson AP.	mBio	10.1128/mbio.03752-21	2022
	Malignant T Cell Activation by a Bacillus Species Isolated from Cutaneous T-Cell Lymphoma Lesions.	Dehner CA, Ruff WE, Greiling T, Pereira MS, Redanz S, McNiff J, Girardi M, Kriegel MA.	JID Innov	10.1016/j.xjidi.2021.100084	2022
	Characterization of the anti-pathogenic, genomic and phenotypic properties of a Lacticaseibacillus rhamnosus VHProbi M14 isolate.	Zhang J, Li K, Bu X, Cheng S, Duan Z.	PLoS One	10.1371/journal.pone.0285480	2023
	Characterization of Vibrio cholerae's Extracellular Nuclease Xds.	Pressler K, Mitterer F, Vorkapic D, Reidl J, Oberer M, Schild S.	Front Microbiol	10.3389/fmicb.2019.02057	2019
Phylogeny	A 16S rRNA Gene and Draft Genome Database for the Murine Oral Bacterial Community.	Joseph S, Aduse-Opoku J, Hashim A, Hanski E, Streich R, Knowles SCL, Pedersen AB, Wade WG, Curtis MA.	mSystems	10.1128/msystems.01222-20	2021
Metabolism	Resistin-like Molecule alpha Provides Vitamin-A-Dependent Antimicrobial Protection in the Skin.	Harris TA, Gattu S, Propheter DC, Kuang Z, Bel S, Ruhn KA, Chara AL, Edwards M, Zhang C, Jo JH, Raj P, Zouboulis CC, Kong HH, Segre JA, Hooper LV.	Cell Host Microbe	10.1016/j.chom.2019.04.004	2019
Pathogenicity	The antimicrobial potential of cannabidiol.	Blaskovich MAT, Kavanagh AM, Elliott AG, Zhang B, Ramu S, Amado M, Lowe GJ, Hinton AO, Pham DMT, Zuegg J, Beare N, Quach D, Sharp MD, Pogliano J, Rogers AP, Lyras D, Tan L, West NP, Crawford DW, Peterson ML, Callahan M, Thurn M.	Commun Biol	10.1038/s42003-020-01530-y	2021
	Carbon source competition within the wound microenvironment can significantly influence infection progression.	Maslova E, EisaianKhongi L, Rigole P, Coenye T, McCarthy RR.	NPJ Biofilms Microbiomes	10.1038/s41522-024-00518-4	2024
Genetics	Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.	Corvec S.	Clin Microbiol Rev	10.1128/cmr.00064-17	2018
Phylogeny	Microbial Communities in the Extraradicular and Intraradicular Infections Associated With Persistent Apical Periodontitis.	Sun X, Yang Z, Nie Y, Hou B.	Front Cell Infect Microbiol	10.3389/fcimb.2021.798367	2021
Phylogeny	Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues.	Borgognone A, Serna G, Noguera-Julian M, Alonso L, Parera M, Catala-Moll F, Sanchez L, Fasani R, Paredes R, Nuciforo P.	Cancers (Basel)	10.3390/cancers13215421	2021
Biotechnology	Discovery and Biotechnological Exploitation of Glycoside-Phosphorylases.	Li A, Benkoulouche M, Ladeveze S, Durand J, Cioci G, Laville E, Potocki-Veronese G.	Int J Mol Sci	10.3390/ijms23063043	2022
Pathogenicity	Comparative antibacterial activity of N-terminal and C-terminal domains of a recombinant endolysin against Cutibacterium acnes.	Lee J-H, Hasnain MA, Park J-H, Choi W, Moon G-S.	Appl Environ Microbiol	10.1128/aem.01168-25	2025
	Differential Modulation of Skin Barrier Proteins and Lipid Synthesis by Staphylococcus aureus, Staphylococcus hominis, and Cutibacterium acnes.	Kim H, Kim A, Kim H, Seo D, Son S, Kim D, Shin JU.	Ann Dermatol	10.5021/ad.25.020	2025
	Expression of a recombinant endolysin from bacteriophage CAP 10-3 with lytic activity against Cutibacterium acnes.	Kim JI, Hasnain MA, Moon GS.	Sci Rep	10.1038/s41598-023-43559-z	2023
	Cutibacterium acnes KCTC 3314 Growth Reduction with the Combined Use of Bacteriophage PAP 1-1 and Nisin.	Han MH, Khan SA, Moon GS.	Antibiotics (Basel)	10.3390/antibiotics12061035	2023
	Antimicrobial Activity of Smilax china L. Root Extracts against the Acne-Causing Bacterium, Cutibacterium acnes, and Its Active Compounds.	Joo JH, Han MH, Kim JI, Kim JE, Jung KH, Oh HS, Chung YS, An HJ, Lee JD, Moon GS, Lee HY.	Molecules	10.3390/molecules27238331	2022
	Transcriptomic analysis of the antimicrobial activity of prodigiosin against Cutibacterium acnes.	Kim HJ, Lee MS, Jeong SK, Lee SJ.	Sci Rep	10.1038/s41598-023-44612-7	2023
Pathogenicity	Effect of afzelin on inflammation and lipogenesis in particulate matter-stimulated C. acnes-treated SZ95 sebocytes.	Hong JY, Choi YH, Roh YJ, Lee MK, Zouboulis CC, Park KY.	Front Med (Lausanne)	10.3389/fmed.2025.1518382	2025
	Evaluation of the EtOAc Extract of Lemongrass (Cymbopogon citratus) as a Potential Skincare Cosmetic Material for Acne Vulgaris.	Kim C, Park J, Lee H, Hwang DY, Park SH, Lee H.	J Microbiol Biotechnol	10.4014/jmb.2201.01037	2022
	Multifunctional Microneedle Patch with Diphlorethohydroxycarmalol for Potential Wound Dressing.	Kim TH, Kim MS, Kim NG, Linh NV, Doan HV, Kim YM, Park SH, Jung WK.	Tissue Eng Regen Med	10.1007/s13770-024-00655-z	2024
Pathogenicity	Inhibitory Effects of a Sargassum miyabei Yendo on Cutibacterium acnes-Induced Skin Inflammation.	Yim MJ, Lee JM, Kim HS, Choi G, Kim YM, Lee DS, Choi IW.	Nutrients	10.3390/nu12092620	2020
	Wnt-activating human skin organoid model of atopic dermatitis induced by Staphylococcus aureus and its protective effects by Cutibacterium acnes.	Jung SY, You HJ, Kim MJ, Ko G, Lee S, Kang KS.	iScience	10.1016/j.isci.2022.105150	2022
	Influence of Panax ginseng formulation on skin microbiota: A randomized, split face comparative clinical study.	Hou JH, Shin H, Shin H, Kil Y, Yang DH, Park MK, Lee W, Seong JY, Lee SH, Cho HS, Yuk SH, Lee KY.	J Ginseng Res	10.1016/j.jgr.2021.12.002	2022
Pathogenicity	Synergistic Antibacterial Activity of an Active Compound Derived from Sedum takesimense against Methicillin-Resistant Staphylococcus aureus and Its Clinical Isolates.	Jeong ET, Park SK, Jo DM, Khan F, Choi TH, Yoon TM, Kim YM.	J Microbiol Biotechnol	10.4014/jmb.2105.05015	2021
	Bioactive Compounds from Medicinal Plants as Potential Adjuvants in the Treatment of Mild Acne Vulgaris.	Cristani M, Micale N.	Molecules	10.3390/molecules29102394	2024
Pathogenicity	Target Proteins of Phloretin for Its Anti-Inflammatory and Antibacterial Activities Against Propionibacterium acnes-Induced Skin Infection.	Cheon D, Kim J, Jeon D, Shin HC, Kim Y.	Molecules	10.3390/molecules24071319	2019
Metabolism	Diving beetle-like miniaturized plungers with reversible, rapid biofluid capturing for machine learning-based care of skin disease.	Baik S, Lee J, Jeon EJ, Park BY, Kim DW, Song JH, Lee HJ, Han SY, Cho SW, Pang C.	Sci Adv	10.1126/sciadv.abf5695	2021
	Open-Label, Prospective Study of a Prebiotic Gel Cream on Its Efficacy of Mild to Moderate Acne Management and Effects on the Functional Skin Microbiome.	Afzal L, Dulai AS, Khan ZE, Nguyen N, Afzal N, Gunt HB, Sivamani RK.	J Cosmet Dermatol	10.1111/jocd.70138	2025
	Do Melanocytes Have a Role in Controlling Epidermal Bacterial Colonisation and the Skin Microbiome?	Bi O, Caballero-Lima D, Sikkink S, Westgate G, Kauser S, Elies J, Thornton MJ.	Exp Dermatol	10.1111/exd.70071	2025
	Intracellular Detection of C. acnes and S. aureus in Non-Herniated Human Intervertebral Discs: Implications for Catabolic Signaling Pathways.	Nuesch A, Kanelis E, Alexopoulos LG, Gantenbein B, Lacey M, Le Maitre CL.	JOR Spine	10.1002/jsp2.70139	2025
	Integrative Metatranscriptomic Analysis Reveals Disease-specific Microbiome-host Interactions in Oral Squamous Cell Carcinoma.	Jain V, Baraniya D, El-Hadedy DE, Chen T, Slifker M, Alakwaa F, Cai KQ, Chitrala KN, Fundakowski C, Al-Hebshi NN.	Cancer Res Commun	10.1158/2767-9764.crc-22-0349	2023
	Development of a topical bacteriophage gel targeting Cutibacterium acnes for acne prone skin and results of a phase 1 cosmetic randomized clinical trial.	Golembo M, Puttagunta S, Rappo U, Weinstock E, Engelstein R, Gahali-Sass I, Moses A, Kario E, Ben-Dor Cohen E, Nicenboim J, Ben David H, Sudakov K, Cohen A, Bassan M, Zak NB.	Skin Health Dis	10.1002/ski2.93	2022
	Bio-Based Nano-Enabled Cosmetic Formulations for the Treatment of Cutibacterium acnes-Associated Skin Infections.	Ivanova K, Ramon E, Ivanova A, Sanchez-Gomez S, Tzanov T.	Antioxidants (Basel)	10.3390/antiox12020432	2023
	Molecular Diversity and Biochemical Content in Two Invasive Alien Species: Looking for Chemical Similarities and Bioactivities.	Vega J, Catala TS, Garcia-Marquez J, Speidel LG, Arijo S, Cornelius Kunz N, Geisler C, Figueroa FL.	Mar Drugs	10.3390/md21010005	2022
	Carotenoids from Persimmon (Diospyros kaki Thunb.) Byproducts Exert Photoprotective, Antioxidative and Microbial Anti-Adhesive Effects on HaCaT.	Gea-Botella S, Moreno-Chamba B, de la Casa L, Salazar-Bermeo J, Marti N, Martinez-Madrid MC, Valero M, Saura D.	Pharmaceutics	10.3390/pharmaceutics13111898	2021
	Characterization of the novel Cutibacterium acnes phage KIT08 and its associated pseudolysogenic bacterial isolate.	Nguyen PD, Nakanishi K, Hosokawa C, Han NS, Kitao M, Yoshimoto M, Kamei K.	Arch Microbiol	10.1007/s00203-025-04451-8	2025
	Direct and Indirect Bactericidal Effects of Cold Atmospheric-Pressure Microplasma and Plasma Jet.	Yahaya AG, Okuyama T, Kristof J, Blajan MG, Shimizu K.	Molecules	10.3390/molecules26092523	2021
	Efficacy of Three Povidone Iodine Formulations against Cutibacterium acnes Assessed through In Vitro Studies: A Preliminary Study.	Pichon M, Burucoa C, Evplanov V, Favalli F	Antibiotics (Basel)	10.3390/antibiotics11050665	2022
Cultivation	Coculture method for in vitro cultivation of uncultured oral bacteria.	Kusugal P, Bhat KG, Ingalagi P, Patil S, Pattar G	J Oral Maxillofac Pathol	10.4103/0973-029X.325125	2021
Pathogenicity	Interaction of implant infection-related commensal bacteria with mesenchymal stem cells: a comparison between Cutibacterium acnes and Staphylococcus aureus.	El-Mahdy TS, Mongaret C, Varin-Simon J, Lamret F, Vernet-Garnier V, Rammal H, Mauprivez C, Kerdjoudj H, Gangloff SC, Reffuveille F	FEMS Microbiol Lett	10.1093/femsle/fnab014	2021
	Effectiveness of topical adjuvants in reducing biofilm formation on orthopedic implants: an in vitro analysis.	Kia C, Cusano A, Messina J, Muench LN, Chadayammuri V, McCarthy MB, Umejiego E, Mazzocca AD	J Shoulder Elbow Surg	10.1016/j.jse.2020.12.009	2021
Pathogenicity	Evaluation of tea tree oil physicochemical features and its antimicrobial activity against Cutibacterium acnes (Propionibacterium acnes) ATCC 6919	Ossa-Tabares JC, Llanos CJ, Garcia AM	Biomedica	10.7705/biomedica.5122	2020
Enzymology	Saponin fraction from Sapindus mukorossi Gaertn as a novel cosmetic additive: Extraction, biological evaluation, analysis of anti-acne mechanism and toxicity prediction.	Wei MP, Qiu JD, Li L, Xie YF, Yu H, Guo YH, Yao WR	J Ethnopharmacol	10.1016/j.jep.2020.113552	2020
Genetics	Complete Genome Sequences and Methylome Analyses of Cutibacterium acnes subsp. acnes Strains DSM 16379 and DSM 1897(T).	Deptula P, Laine P, Paulin L, Auvinen P, Roberts RJ, Johnston CD, Varmanen P	Microbiol Resour Announc	10.1128/MRA.00705-20	2020
Metabolism	Caenorhabditis elegans mounts a p38 MAPK pathway-mediated defence to Cutibacterium acnes infection.	Huang X, Pan W, Kim W, White A, Li S, Li H, Lee K, Fuchs BB, Zeng K, Mylonakis E	Cell Microbiol	10.1111/cmi.13234	2020
Pathogenicity	Rosa davurica Pall. Improves Propionibacterium acnes-Induced Inflammatory Responses in Mouse Ear Edema Model and Suppresses Pro-Inflammatory Chemokine Production via MAPK and NF-kappaB Pathways in HaCaT Cells.	Hwang DH, Lee DY, Koh PO, Yang HR, Kang C, Kim E	Int J Mol Sci	10.3390/ijms21051717	2020
	Exploring the Anti-Acne Potential of Impepho [Helichrysum odoratissimum (L.) Sweet] to Combat Cutibacterium acnes Virulence.	De Canha MN, Komarnytsky S, Langhansova L, Lall N	Front Pharmacol	10.3389/fphar.2019.01559	2020
Pathogenicity	Synthesis and evaluation of biological activity of benzoxaborole derivatives of azithromycin.	Tevyashova AN, Korolev AM, Mirchink EP, Isakova EB, Osterman IA	J Antibiot (Tokyo)	10.1038/s41429-018-0107-2	2018
Pathogenicity	Mikania glomerata Sprengel extract and its major compound ent-kaurenoic acid display activity against bacteria present in endodontic infections.	Moreti DLC, Leandro LF, da Silva Moraes T, Moreira MR, Sola Veneziani RC, Ambrosio SR, Gomes BP, Martins CHG	Anaerobe	10.1016/j.anaerobe.2017.06.008	2017
Pathogenicity	A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes.	Nair SS, Zolotarskaya OY, Beckwith MJ, Ohman DE, Wynne KJ	Macromol Biosci	10.1002/mabi.201700090	2017
Pathogenicity	N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens.	Eroshenko D, Polyudova T, Korobov V	Microb Pathog	10.1016/j.micpath.2017.02.030	2017
Pathogenicity	Interaction of Cutibacterium ( formerly Propionibacterium) acnes with bone cells: a step toward understanding bone and joint infection development.	Aubin GG, Baud'huin M, Lavigne JP, Brion R, Gouin F, Lepelletier D, Jacqueline C, Heymann D, Asehnoune K, Corvec S	Sci Rep	10.1038/srep42918	2017
Proteome	Analysis of the Surface, Secreted, and Intracellular Proteome of Propionibacterium acnes.	Yu Y, Champer J, Kim J	EuPA Open Proteom	10.1016/j.euprot.2015.06.003	2015
Pathogenicity	Chemical Composition of the Essential Oil from Croton oblongifolius and its Antibacterial Activity against Propionibacterium acnes.	Athikomkulchai S, Tadtong S, Ruangrungsi N, Hongratanaworakit T	Nat Prod Commun		2015
Pathogenicity	Antimicrobial photodynamic therapy using chlorin e6 with halogen light for acne bacteria-induced inflammation.	Jeon YM, Lee HS, Jeong D, Oh HK, Ra KH, Lee MY	Life Sci	10.1016/j.lfs.2014.12.029	2015
Genetics	Draft Genome Sequences of Propionibacterium acnes Type Strain ATCC6919 and Antibiotic-Resistant Strain HL411PA1.	Liu J, Cheng A, Bangayan NJ, Barnard E, Curd E, Craft N, Li H	Genome Announc	10.1128/genomeA.00740-14	2014
Metabolism	5alpha-Androst-16-en-3alpha-ol beta-D-glucuronide, precursor of 5alpha-androst-16-en-3alpha-ol in human sweat.	Starkenmann C, Mayenzet F, Brauchli R, Troccaz M	Chem Biodivers	10.1002/cbdv.201300286	2013
Pathogenicity	Evaluation of antibacterial and anti-inflammatory activities of less polar ginsenosides produced from polar ginsenosides by heat-transformation.	Wang L, Yang X, Yu X, Yao Y, Ren G	J Agric Food Chem	10.1021/jf404461q	2013
Pathogenicity	Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes.	Lee SE, Kim JM, Jeong SK, Jeon JE, Yoon HJ, Jeong MK, Lee SH	Arch Dermatol Res	10.1007/s00403-010-1074-z	2010
Pathogenicity	Syntheses of carnosic acid and carnosol, anti-oxidants in Rosemary, from pisiferic acid, the major constituent of Sawara.	Tada M, Ohkanda T, Kurabe J	Chem Pharm Bull (Tokyo)	10.1248/cpb.58.27	2010
Metabolism	Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro.	Iinuma K, Sato T, Akimoto N, Noguchi N, Sasatsu M, Nishijima S, Kurokawa I, Ito A	J Invest Dermatol	10.1038/jid.2009.46	2009
Enzymology	Cloning and expression of antibacterial goat lactoferricin from Escherichia coli AD494(DE3)pLysS expression system.	Chen GH, Yin LJ, Chiang IH, Jiang ST	J Food Prot	10.4315/0362-028x-71.12.2523	2008
Enzymology	Characterization of beta-1,3-galactosyl-N-acetylhexosamine phosphorylase from Propionibacterium acnes.	Nakajima M, Nishimoto M, Kitaoka M	Appl Microbiol Biotechnol	10.1007/s00253-008-1838-y	2009
Phylogeny	A new phylogenetic group of Propionibacterium acnes.	McDowell A, Perry AL, Lambert PA, Patrick S	J Med Microbiol	10.1099/jmm.0.47489-0	2008
Enzymology	Linoleic acid isomerase from Propionibacterium acnes: purification, characterization, molecular cloning, and heterologous expression.	Deng MD, Grund AD, Schneider KJ, Langley KM, Wassink SL, Peng SS, Rosson RA	Appl Biochem Biotechnol	10.1007/s12010-007-8075-1	2007
Pathogenicity	Biofilm formation of the pathogens of fatal bacterial granuloma after trauma: potential mechanism underlying the failure of traditional antibiotic treatments.	Qi X, Gao J, Sun D, Liang W, Wan Y, Li C, Xu X, Gao T	Scand J Infect Dis	10.1080/00365540701632998	2007
Pathogenicity	Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.	Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJ	Food Chem Toxicol	10.1016/j.fct.2005.08.008	2006
Pathogenicity	Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.	Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJ	Food Chem Toxicol	10.1016/j.fct.2005.08.030	2005
Metabolism	CAMP factor homologues in Propionibacterium acnes: a new protein family differentially expressed by types I and II.	Valanne S, McDowell A, Ramage G, Tunney MM, Einarsson GG, O'Hagan S, Wisdom GB, Fairley D, Bhatia A, Maisonneuve JF, Lodes M, Persing DH, Patrick S	Microbiology (Reading)	10.1099/mic.0.27788-0	2005
Metabolism	Hydrogel patches containing triclosan for acne treatment.	Lee TW, Kim JC, Hwang SJ	Eur J Pharm Biopharm	10.1016/s0939-6411(03)00137-1	2003
Enzymology	In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.	Yamakawa T, Mitsuyama J, Hayashi K	J Antimicrob Chemother	10.1093/jac/49.3.455	2002
Metabolism	Biotyping of Propionibacterium acnes isolated from normal human facial skin.	Kishishita M, Ushijima T, Ozaki Y, Ito Y	Appl Environ Microbiol	10.1128/aem.38.4.585-589.1979	1979
	Anaerobic flora, Selenomonas ruminis sp. nov., and the bacteriocinogenic Ligilactobacillus salivarius strain MP3 from crossbred-lactating goats.	Poothong S, Tanasupawat S, Chanpongsang S, Kingkaew E, Nuengjamnong C.	Sci Rep	10.1038/s41598-024-54686-6	2024
Phylogeny	Emendation of Propionibacterium acnes subsp. acnes (Deiko et al. 2015) and proposal of Propionibacterium acnes type II as Propionibacterium acnes subsp. defendens subsp. nov.	McDowell A, Barnard E, Liu J, Li H, Patrick S	Int J Syst Evol Microbiol	10.1099/ijsem.0.001521	2016
Phylogeny	Propionibacterium namnetense sp. nov., isolated from a human bone infection.	Aubin GG, Bemer P, Kambarev S, Patel NB, Lemenand O, Caillon J, Lawson PA, Corvec S	Int J Syst Evol Microbiol	10.1099/ijsem.0.001204	2016
Phylogeny	Dissecting the taxonomic heterogeneity within Propionibacterium acnes: proposal for Propionibacterium acnes subsp. acnes subsp. nov. and Propionibacterium acnes subsp. elongatum subsp. nov.	Dekio I, Culak R, Misra R, Gaulton T, Fang M, Sakamoto M, Ohkuma M, Oshima K, Hattori M, Klenk HP, Rajendram D, Gharbia SE, Shah HN	Int J Syst Evol Microbiol	10.1099/ijsem.0.000648	2015

References

#919	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 1897
#20215	Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )
#20218	Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )
#24963	C. F. P. K. Scholz, Mogens: The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov.. IJSEM 66: 4422 - 4432 2016 ( DOI 10.1099/ijsem.0.001367 , PubMed 27488827 )
#42199	; Curators of the CIP;
#44423	Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 1794
#66792	Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .
#67770	Japan Collection of Microorganism (JCM) ; Curators of the JCM;
#68380	Automatically annotated from API rID32A .
#68382	Automatically annotated from API zym .
#69479	João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .
#116031	Collection of Institut Pasteur ; Curators of the CIP; CIP 53.117
#124043	Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy .
#125438	Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 )
#125439	Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 .
#126262	A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 )

@ref	URE	ADH (Arg)	alpha GAL	beta GAL	beta-Galactosidase 6-phosphatebeta GP	alpha GLU	beta GLU	alpha ARA	beta GUR	beta-N-Acetyl-beta-glucosaminidasebeta NAG	MNE	RAF	GDC	alpha FUC	Reduction of nitrateNIT	IND	PAL	L-arginine arylamidaseArgA	ProA	LGA	Phenylalanine arylamidasePheA	Leucine arylamidaseLeuA	PyrA	Tyrosine arylamidaseTyrA	Alanine arylamidaseAlaA	Glycin arylamidaseGlyA	Histidine arylamidaseHisA	Glutamyl-glutamate arylamidaseGGA	Serine arylamidaseSerA
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	+/-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	-	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	-
919	-	+	-	+/-	-	-	-	-	-	+	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	-	+	-	+/-	+	-	-	-	-	-	+	+	-	-	+
919	-	-	-	+	-	-	-	-	-	+/-	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+/-	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+/-	+	-	-	-	+	+	-	+/-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	+	-	-	-	-	+	+	-	-	+

@ref	URE	ADH (Arg)	alpha GAL	beta GAL	beta-Galactosidase 6-phosphatebeta GP	alpha GLU	beta GLU	alpha ARA	beta GUR	beta-N-Acetyl-beta-glucosaminidasebeta NAG	MNE	RAF	GDC	alpha FUC	Reduction of nitrateNIT	IND	PAL	L-arginine arylamidaseArgA	ProA	LGA	Phenylalanine arylamidasePheA	Leucine arylamidaseLeuA	PyrA	Tyrosine arylamidaseTyrA	Alanine arylamidaseAlaA	Glycin arylamidaseGlyA	Histidine arylamidaseHisA	Glutamyl-glutamate arylamidaseGGA	Serine arylamidaseSerA
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	+/-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	-	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	-
919	-	+	-	+/-	-	-	-	-	-	+	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	-	+	-	+/-	+	-	-	-	-	-	+	+	-	-	+
919	-	-	-	+	-	-	-	-	-	+/-	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+/-	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+/-	+	-	-	-	+	+	-	+/-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	+	-	-	-	-	+	+	-	-	+

Rate our new design

Content

About us

Cutibacterium acnes subsp. acnes (LMG 16711, DSM 1897, ATCC 6919)

Name and taxonomic classification

Morphology

Cell morphology

Colony morphology

Culture and growth conditions

Culture medium

Culture temp

Culture pH

Physiology and metabolism

Oxygen tolerance

Spore formation

Compound production

Murein

Metabolite utilization

Metabolite production

Metabolite tests

Enzymes

API zym

API rID32A

API biotype100

Isolation, sampling and environmental information

Isolation source categories

Isolation

Taxonmaps

Interaction and safety

Risk assessment

Sequence information

Genome sequences

Genome browser: GCA_006739385

16S sequences

GC content

Genome-based predictions

Predictions

Literature

Literature

References

BacDive

Help

Social Media

@ref	URE	ADH (Arg)	alpha GAL	beta GAL	beta-Galactosidase 6-phosphatebeta GP	alpha GLU	beta GLU	alpha ARA	beta GUR	beta-N-Acetyl-beta-glucosaminidasebeta NAG	MNE	RAF	GDC	alpha FUC	Reduction of nitrateNIT	IND	PAL	L-arginine arylamidaseArgA	ProA	LGA	Phenylalanine arylamidasePheA	Leucine arylamidaseLeuA	PyrA	Tyrosine arylamidaseTyrA	Alanine arylamidaseAlaA	Glycin arylamidaseGlyA	Histidine arylamidaseHisA	Glutamyl-glutamate arylamidaseGGA	Serine arylamidaseSerA
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	+/-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	-	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	-
919	-	+	-	+/-	-	-	-	-	-	+	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	-	+	-	+/-	+	-	-	-	-	-	+	+	-	-	+
919	-	-	-	+	-	-	-	-	-	+/-	+	-	-	-	+	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+/-	+	-	-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+/-	+	-	-	-	+	+	-	+/-	+	-	-	-	-	-	+	+	-	-	+
919	-	+	-	+	-	-	-	-	-	+	+	-	-	-	+	+	-	+	+	+	-	-	-	-	+	+	-	-	+